Cell viability after cryopreservation is a sensitive subject as it may be dependent on the ability of mammalian cells to face the stress generated by the freeze / thaw cycles. Improving cell viability whilst maintaining optimal cellular functions and pathways has thus become a challenge. In this post, we invite you to take a look at 3 optimized reagents to improve cellular viability after cryopreservation with serum-free and protein-free CryoStor cryopreservation freeze media solutions.
VitroGel™ 3D (TheWell Bioscience) is an animal origin-free hydrogel system closely mimicking the natural extracellular matrix (ECM) environment. Cells grown in this 3D hydrogel possess morphologies and cellular behaviours close to their natural state making it ideal for 3D cell culture.
cellphy – study the human body in a petri dish
Therefore, VitroGel™ 3D fits perfectly with our “cellphy” offer, providing life scientists with reagents and laboratory services mimicking the physiological environment of the Human body in vitro, for more physiologically relevant experimental data.
You can choose between two:
- VitroGel™ 3D (cat. nr TWG001): an animal origin-free hydrogel system mimicking the natural ECM, ideal option for floating cell lines.
- VitroGel™ 3D-RGD (cat. nr TWG002): RGD peptide modified hydrogel of VitroGel 3D promoting cell attachment and cell-matrix interactions for 3D-culture and 2D-coating (invasion/migration, chemiotaxis…). Best solution for adhesion cell lines.
This year again, we were pleased to attend the Annual meeting of the AACR (American Association for Cancer Research), which took place in Chicago, USA earlier this month.
Dora Sabino PhD of tebu-bio at the AACR2018 Poster Session
Dora Sabino PhD of tebu-bio at the AACR2018 Poster Session
Dora Sabino PhD of tebu-bio at the AACR2018 Poster Session
Dora Sabino Ph.D. (3D Cell Culture Project Manager, tebu-bio) presented a poster covering a physiologically relevant study on 3D colon cancer models in microfluidic chips:
“Time-lapse analysis of drug response and invasive capacity using patient-derived and CRC microfluidic 3D cancer models under oxygen controlled conditions”
Download your copy of the poster here and learn more about tebu-bio’s laboratory outsourcing solutions.
Top contributors
